Giannis Mountzios: Keith Kerr on the role of pathology in the optimal management of Thoracic Malignancies
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, reshared a post by ESMO – European Society for Medical Oncology on LinkedIn:
The so well deserved award to Prof Keith Kerr, a mentor to molecular pathology to so many of us, exemplifies the need to emphasize on the role of pathology in the optimal management of Thoracic Malignancies.
The Pathologist is our “eyes” to the tumor and much more, to molecular profile leading to personalized treatment.”
Quoting ESMO – European Society for Medical Oncology‘s post:
“Is it time for pathologists to take a more active role in Lung Cancer?
2025 Heine H. Hansen Award recipient, Keith Kerr, explains how lung cancer pathology has evolved over the years.
He describes today’s priorities including identifying pathological characteristics as biomarkers, integrating complex genomic information and learning how best to leverage AI to advance the field further.
Read his full interview in the ESMO Daily Reporter.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023